Fermentalg DHA range to enter US market under new partnership

03 Apr 2018 --- French microalgae supplier Fermentalg has obtained Generally Recognized As Safe (GRAS) status for its algal oils which are “naturally rich in omega 3” and they have signed a distribution agreement with Stauber for the US and Canada. These steps represent Fermentalg’ success in driving its DHA origins range on the US market.

The DHA origins range include DHA origins 350, an oil with a natural DHA concentration of 350 mg/g, and DHA origins 550, the first algal oil with a minimum natural DHA concentration of 550 mg/g.

The distribution agreement was signed with Stauber: a US ingredient supplier who have served the nutritional, dietary supplement and functional food & beverage industries since 1969. Stauber has been rated as number 1 for overall performance among USA distributors in the area of Customer Service, On-Time Delivery and Product Quality, they claim. This partnership, in conjunction with GRAS status, means that DHA Origins may be sold in applications dedicated to human nutrition including baby food.

“After gaining authorization in Europe for our DHA-rich algal oils and signing the distribution agreement with IMCD Group, we have proved our ability to penetrate the US market and deploy a resolutely global strategy for our products. We look forward to presenting DHA origins550, an innovative addition to our omega-3 rich algal oil range that strengthens Fermentalg's positioning on nutrition and health markets, at the Vitafoods trade fair in Geneva next May,” says Philippe Lavielle, Fermentalg Chairman and CEO of Fermentalg.

Fermentalg enjoyed growth in 2017, which included two notable partnerships. 

Firstly, they signed a first distribution agreement for algal oils with specialty chemicals and food ingredients company IMCD Group. This represented a secure entry into the European market.

Furthermore, Fermentalg also reported that third-quarter 2017 was also marked by the signature of a two-component strategic partnership agreement with Japanese global chemicals company DIC Corporation. This partnership was designed to allow the company to step up its presence in the health and nutrition market, with a substantial financial investment and a three-year joint development program for two micro-algae derived natural pigments.

Fermentalg also reported in 2017 a €12.6 million in funds as part of a capital increase with preferential subscription rights maintained, which was 1.6 times oversubscribed

It was foreseen that these milestones placed Fermentalg in good stead for growth.